- Home
- NLSP vs NEN Comparison
NLSP vs NEN Comparison
Compare NLSP & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- NEN
- Stock Information
- Founded
- NLSP 2015
- NEN 1977
- Country
- NLSP Switzerland
- NEN United States
- Employees
- NLSP N/A
- NEN N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- NEN Building operators
- Sector
- NLSP Health Care
- NEN Real Estate
- Exchange
- NLSP Nasdaq
- NEN Nasdaq
- Market Cap
- NLSP 12.4M
- NEN 262.4M
- IPO Year
- NLSP 2021
- NEN N/A
- Fundamental
- Price
- NLSP $2.10
- NEN $73.02
- Analyst Decision
- NLSP
- NEN
- Analyst Count
- NLSP 0
- NEN 0
- Target Price
- NLSP N/A
- NEN N/A
- AVG Volume (30 Days)
- NLSP 275.3K
- NEN 594.0
- Earning Date
- NLSP 07-22-2025
- NEN 01-01-0001
- Dividend Yield
- NLSP N/A
- NEN 6.49%
- EPS Growth
- NLSP N/A
- NEN 58.97
- EPS
- NLSP N/A
- NEN 4.56
- Revenue
- NLSP N/A
- NEN $82,531,485.00
- Revenue This Year
- NLSP N/A
- NEN N/A
- Revenue Next Year
- NLSP N/A
- NEN N/A
- P/E Ratio
- NLSP N/A
- NEN $16.22
- Revenue Growth
- NLSP N/A
- NEN 6.12
- 52 Week Low
- NLSP $1.30
- NEN $68.98
- 52 Week High
- NLSP $15.59
- NEN $84.00
- Technical
- Relative Strength Index (RSI)
- NLSP 46.61
- NEN 47.71
- Support Level
- NLSP $2.20
- NEN $73.00
- Resistance Level
- NLSP $3.08
- NEN $73.25
- Average True Range (ATR)
- NLSP 0.25
- NEN 0.22
- MACD
- NLSP -0.06
- NEN 0.16
- Stochastic Oscillator
- NLSP 8.40
- NEN 67.11
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.